96740 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids
Prophylactic protection against viral infections, particularly HIV
#2102Antibacterial cyclic lipopeptides
#2103Delta receptor agonist peptides and use thereof
#2104METHOD FOR PURIFYING PROTEIN
#2105Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#2106Programmable polypeptide and nucleic acid nanoparticles
#2107Immunomodulators
#2108CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS
#2109Immune System Modulation for Prophylaxis and Treatment of Diseases and Disorders
#2110Peptide inhibitors of calcium oxalate monohydrate crystallization and uses thereof
#2111COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR WOUND HEALING
#2112Use of inhibitory peptides for the treatment of inflammatory diseases
#2113LINACLOTIDE COMPOSITIONS
#2114Peptidomimetic macrocycles
#2115METHOD TO CONCENTRATE APOA-1 MIMETIC PEPTIDES TRANSGENICALLY EXPRESSED IN PLANTS
#2116Peptide and use thereof
#2117IMPROVED PROCESS FOR PREPARATION OF AMORPHOUS LINACLOTIDE
#2118NOVEL PEPTIDE COMPOSITIONS
#2119Mycobacterium Antigens
#2120Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit
#2121Peptide microarrays and novel biomarkers for celiac disease
#2122Peptides for treating bone diseases and use thereof
#2123Inhibitory peptides of viral infection
#2124TARGETED ANTIMICROBIAL MOIETIES
#2125Construct for the delivery of a molecule into the cytoplasm of a cell
#2126Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
#2127Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions
#2128POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF
#2129Cell penetrating peptides for intracellular delivery of molecules
#2130Quantification of vaccine compositions
#2131Polypeptide inhibitors of Smad3 polypeptide activities
#2132Functional Peptide Analogs of PEDF
#2133Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers
#2134Inhibition of pulmonary fibrosis with nutlin-3a and peptides
#2135Immunomodulators
#2136Method for efficient delivery of therapeutic molecules in vitro and in vivo
#2137Norovirus antibodies
#2138STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION
#2139EXTRACELLULAR MATRIX METALLOPROTEINASE INDUCER (EMMPRIN) PEPTIDES AND BINDING ANTIBODIES
#2140Anti-microbial peptides
#2141Compstatin analogs with improved pharmacokinetic properties
#2142Peptide reagents and methods for detection and targeting of dysplasia, early cancer and cancer
#2143PEPTIDES FOR BINDING ALTERNATIVELY ACTIVATED MACROPHAGES
#2144Cell penetrating peptide, conjugate thereof with botulinum toxin, and use thereof
#2145Process for the preparation of linaclotide
#2146Advanced macromolecule transduction domain (aMTD) sequences for improvement of cell-permeability, polynucleotides encoding the same, method to identify the unique features of aMTDs comprising the same, method to develop the aMTD sequences comprising the same
#2147In vivo methods of monitoring biodistribution
#2148Prostate-specific membrane antigen (PSMA) targeting peptides
#2149Therapeutic Use of Peptide Inhibitors of NADPH Oxidase; Aerosolization as a Delivery Mechanism
#2150Methods and compositions related to inhibition of viral entry
#2151Targeted/TGF-ßRII fusion proteins and methods for making same
#2152Telomerase polypeptide vaccine for treating cancer
#2153Telomerase polypeptide vaccine for treating cancer
#2154Method for minimising progression of cancer in companion animals
#2155Markers for mood disorders
#2156Metallothionein-derived peptide fragments
#2157Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof
#2158COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES
#2159Methods for inhibiting immune complex formation in a subject
#2160Solid phase peptide synthesis
#2161Functional lipid constructs
#2162SYNTHETIC ANALOGUES OF NEURAL REGENERATION PEPTIDES
#2163Targeted conformationally-constrained kinked endosomal disrupting peptides
#2164Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making
#2165Peptide for inducing multinucleation in cells, and use therefor
#2166Melanocortin 1 receptor ligands and methods of use
#2167Selected reaction monitoring assays
#2168Antibody-binding polypeptide, antibody-binding fusion polypeptide, and adsorption material
#2169Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
#2170Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
#2171Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity
#2172Antimicrobial peptides
#2173ANTAGONISTIC PEPTIDES
#2174Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
#2175Sterilization and filtration of peptide compositions
#2176Formulations of guanylate cyclase C agonists and methods of use
#2177Formulations of guanylate cyclase C agonists and methods of use
#2178Compositions and methods for regulating glucose metabolism
#2179CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF
#2180COMPOSITION FOR TREATING SEPSIS OR SEPTIC SHOCK COMPRISING THE PEPTIDE ORIGINATED FROM THE SMAD6
#2181KIF20A epitope peptides for TH1 cells and vaccines containing the same
#2182Polypeptides derived from calcitonin receptors and methods of use
#2183Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof
#2184RECOMBINANT POLYPEPTIDE FOR PROMOTING SCARLESS WOUND HEALING AND BIOADHESIVE MATERIAL INCLUDING THE SAME
#2185COMPSTATIN ANALOGS WITH IMPROVED ACTIVITY
#2186Composition and methods for tethering bioactive peptides to metal oxide surfaces
#2187Peptides and combination of peptides for use in immunotherapy against various cancers
#2188Peptides and combination of peptides for use in immunotherapy against various cancers
#2189Peptides and combination of peptides for use in immunotherapy against various cancers
#2190Peptides and combination of peptides for use in immunotherapy against various cancers
#2191Peptides and combination of peptides for use in immunotherapy against various cancers
#2192Peptides and combination of peptides for use in immunotherapy against various cancers
#2193Tyrosine kinase biosensors and methods of use
#2194Cardiotonic steroid antagonists and related methods
#2195Compositions and methods for increasing the expression and signalling of proteins on cell surfaces
#2196NOVEL PEPTIDES FOR PREVENTING OR TREATING BONE DISEASES AND USE THEREOF
#2197Cancer targeting by anti-EGFR peptides and applications thereof
#2198Drug delivery enhancement agents
#2199TFPI inhibitors and methods of use
#2200Biologically active peptides
#2201Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
#2202Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2203Isolated donor MHC-derived peptide and uses thereof
#2204Compstatin analogs with improved potency and pharmacokinetic properties
#2205Method for treating blood, blood products and organs
#2206Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2207Peptides and combination of peptides for use in immunotherapy against various cancers
#2208Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#2209Targeting of PELP1 in cancer therapy
#2210β-hairpin peptidomimetics
#2211IDR PEPTIDE COMPOSITIONS AND USE THEREOF FOR TREATMENT OF TH2-DYSREGULATED INFLAMMATORY CONDITIONS
#2212Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders
#2213Multiplexed same type-antigenic peptide
#2214Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics
#2215Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precursors and conjugates thereof
#2216Mucin-associated surface protein as a vaccine against chagas disease
#2217Lytic-peptide-Her2/neu (Human Epidermal growth factor Receptor 2) ligand conjugates and methods of use
#2218TFPI inhibitors and methods of use
#2219Substrates for detection of botulinum neurotoxin
#2220Beta hairpin peptides having antiviral properties against Dengue virus
#2221Lysine monomethylated derivative and corresponding antibody and use thereof
#2222Peptide tag system that spontaneously form an irreversible link to protein partners via isopeptide bonds
#2223Phoenixin peptides
#2224Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof
#2225Diarylsulfide backbone containing photolabile protecting groups
#2226IMMUNOGENIC GLYCOPEPTIDES, COMPOSITION COMPRISING THE GLYCOPEPTIDES AND USE THEREOF
#2227CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF
#2228Antimicrobial peptide dendrimers
#2229Modulation of complement activity
#2230Epitope tag and method for detection and/or purification of tagged polypeptides
#2231Antibody, epitope tag and method for detection, capture and/or purification of tagged polypeptides
#2232NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
#2233Antibody molecule-drug conjugates and uses thereof
#2234Natriuretic polypeptides
#2235Process of preparing guanylate cyclase C agonisys
#2236Peptides with antimicrobial, anticancer and/or wound-healing promoting activities, pharmaceutical compositions containing the same, and use of the peptides with antimicrobial, anticancer and/or wound-healing promoting activities
#2237Anti-malaria compositions and methods
#2238Methods and compositions for targeting progenitor cell lines
#2239Antibody/drug conjugates and methods of use
#2240Chloride salt of TAT-NR2B9c
#2241TARGETING DIMERIZATION OF BAX TO MODULATE BAX ACTIVITY
#2242Compositions and Methods of Treatment of Cancers
#2243ANTIBIOTIC PEPTIDES
#2244Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
#2245Template-fixed peptidomimetics with antimicrobial activity
#2246Modified apidaecin derivatives as antibiotic peptides
#2247Apelin polypeptides
#2248Modified Antimicrobial Peptides
#2249Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy
#2250ACTH prophylactic treatment of renal disorders
#2251METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#2252Peptide ligands for hepatic stellate cells
#2253Chemical and biochemical adducts as biomarkers for organophosphate exposure
#2254Diagnostic reagents
#2255Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
#2256Tumor-targeting compounds
#2257Bispecific peptide conjugate and radioactive bispecific peptide imaging agent
#2258Modified antibiotic peptides having variable systemic release
#2259USE OF PEPTIDIC DRUGS FOR OSTEOPOROSIS TREATMENT AND BONE REGENERATION
#2260Macrocyclic broad spectrum antibiotics
#2261Cell penetrating peptides for intracellular delivery of molecules
#2262Production of highly thermally stable recombinant cholinesterases for the detection, detoxification and decontamination of organophosphorus compounds
#2263Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
#2264RTEF-1 variants and the use thereof for inhibition of angiogenesis
#2265Anti-inflammatory peptides and composition comprising the same
#2266Peptides for preventing or treating bone diseases and use thereof
#2267Novel Peptides for Preventing or Treating Bone Diseases and Use Thereof
#2268Stabilizied bioactive peptides and methods of identification, synthesis and use
#2269Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
#2270Anti-lymphoma peptides
#2271Xenoantigen-displaying anti-cancer vaccines and method of making
#2272Erythrocyte-binding therapeutics
#2273ALPHA3BETA HYDROGEN BOND SURROGATE MACROCYCLES AS MODULATORS OF RAS
#2274Stitched polypeptides
#2275In silico design of peptides equilibrated in a lipid bilayer with partition free energies indicating probability of antimicrobial activity
#2276Covalently linked helicar-anti-helicar antibody conjugates and uses thereof
#2277Composition for organ, tissue, or cell transplantation, kit, and transplantation method
#2278Bioactive peptide complexes
#2279Peptides for treating cancer
#2280Antimicrobial surface
#2281Fusion protein for treating rejection reaction in transplantation
#2282Multi-arm linker for treating rejection reaction in transplantation
#2283Compositions and methods for transport across the blood brain barrier
#2284Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
#2285Method for treating cancer with activated T cells
#2286Peptides of syndecan-1 for inhibiting angiogenesis
#2287JNK inhibitor molecules for treatment of various diseases
#2288Rodent model of prostate cancer
#2289ANTI-INFLAMMATORY NANOFIBERS
#2290Methods of developing selective peptide antagonists
#2291Integrin Antagonists
#2292Selective delivery molecules and methods of use
#2293Peptides for the treatment of cancer
#2294Compositions and methods for treating hepatitis B
#2295variant and method for producing daptomycin using same
#2296Polypeptides having cellobiohydrolase activity and polynucleotides encoding same
#2297Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#2298Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#2299Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#2300Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers
#2301Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#2302Method for treating cancer with an activated T lymphocyte that selectively recognizes a cancer cell consisting of specific peptide
#2303Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#2304Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#2305Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#2306Peptidomimetic compounds
#2307Macrocyclic peptidomimetics for alpha-helix mimicry
#2308COMPOSITIONS AND METHODS FOR TISSUE REPAIR
#2309Peptides and methods of use
#2310Compositions and methods for treating heart disease and/or injury
#2311Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers
#2312GENETICALLY ENGINEERED POLYMER LIBRARIES AND METHODS OF USING THEM
#2313Murine anti-NY-ESO-1 T cell receptors
#2314AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
#2315METHOD OF PRODUCING BIVALIRUDIN
#2316Peptides whose uptake by cells is controllable
#2317Peptides and methods of using same
#2318Peptide sequences and compositions
#2319Suppression of allergic lung inflammation and hyperreactivity
#2320Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#2321Peptides having anti-inflammatory properties
#2322Methods for the treatment of depression and anxiety
#2323Methods for the treatment of central nervous system (CNS) disorders and mood disorders
#2324Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same
#2325CHEMOKINE BINDING POLYPEPTIDES FOR TREATING AUTOIMMUNITY, AND INFLAMMATION
#2326Compositions and methods for recognition of RNA using triple helix forming peptide nucleic acids
#2327AGER-PEPTIDES AND USE THEREOF
#2328Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain
#2329STABILIZED ALPHA HELICAL PEPTIDES AND USES THEREOF
#2330SOCS mimetics for the treatment of diseases
#2331NOVEL PEPTIDES AND PEPTIDE DERIVATIVES AND USES THEREOF
#2332Rare earth material-binding peptide and use thereof
#2333Supramolecular hydrogel of fMLF-based molecules and use thereof
#2334Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#2335EphA2 T-cell epitope agonists and uses therefore
#2336Compositions and methods of using islet neogenesis peptides and analogs thereof
#2337Plant-derived elastin binding protein ligands and methods of using the same
#2338Peptidomimetic macrocycles
#2339PHARMACOLOGICALLY INDUCED TRANSGENE ABLATION SYSTEM
#2340Compositions useful for the treatment of gastrointestinal disorders
#2341Fc fusion proteins comprising novel linkers or arrangements
#2342Engineered potent cytotoxic stapled BH3 peptides
#2343POLYMERS CONTAINING MULTIVALENT AMYLOID-BETA-BINDING D-PEPTIDES AND THEIR USE
#2344Derivative peptide compounds and methods of use
#2345Anti-microbial peptides and method for designing novel anti-microbial peptides
#2346Collagen imaging compositions
#2347POLYPEPTIDE, DNA MOLECULE ENCODING THE POLYPEPTIDE, VECTOR, PREPARATION METHOD AND USE
#2348Immunotherapy against several tumors including neuronal and brain tumors
#2349Immunotherapy against several tumors including neuronal and brain tumors
#2350Immunotherapy against several tumors including neuronal and brain tumors
#2351Immunotherapy against several tumors including neuronal and brain tumors
#2352Immunotherapy against several tumors including neuronal and brain tumors
#2353Immunotherapy against several tumors including neuronal and brain tumors
#2354Collagen Imaging Compositions
#2355Peptide and a use thereof
#2356Composition for treating prostate cancer
#2357Neurodegenerative disorders
#2358IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF
#2359Peptide having cancer selective translocation function and use thereof
#2360TARGETED ENZYME COMPOUNDS AND USES THEREOF
#2361Artificial signal peptide
#2362Peptides having osteoblast growth-promoting activity and use thereof
#2363WT1 antigenic polypeptide, and anti-tumor agent containing said polypeptide
#2364Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses
#2365Self-assembling peptide compositions
#2366Solid phase peptide synthesis via side chain attachment
#2367mTG substrates for covalent conjugation of compounds
#2368Methods for reducing immune responses
#2369Hypersensitive response elicitor peptides and use thereof
#2370Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof
#2371Immunotherapy against several tumors including neuronal and brain tumors
#2372Tumor-targeting polypeptide and application thereof
#2373Compositions for inducing antigen-specific tolerance
#2374Methods for induction of antigen-specific immune tolerance
#2375Compositions for generating immune tolerance by targeting erythrocytes
#2376Elicitor peptides having disrupted hypersensitive response box and use thereof
#2377Elicitor peptides having disrupted hypersensitive response box and use thereof
#2378Hypersensitive response elicitor peptides and use thereof
#2379Compositions and methods for treating acute and chronic pain by local antagonism of CGRP receptors, or combination with sodium channel inhibition or with anti-inflammatory agents
#2380Activatable fibrin-binding probes
#2381Ezrin-derived peptides and pharmaceutical compositions thereof
#2382Pharmaceutical compositions containing peptides derived from human BPLP protein
#2383Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
#2384AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS
#2385Molecular constructs with targeting and effector moieties for treating infectious diseases
#2386Molecular constructs with targeting and effector moieties comprising an SCFV specific for ectodomain of transferrin-1 receptor and fingolimod
#2387Peptide core-based multi-arm linkers for treating infectious diseases
#2388Peptide core-based multi-arm linkers for treating central nervous system diseases
#2389Peptide core-based multi-arm linkers and their applications
#2390Multivalent antibodies
#2391Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
#2392Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
#2393Peptidomimetic macrocycles and uses thereof
#2394Treatment of ocular disorders with anti-connexin proteins and mimetics
#2395Selectively targeted antimicrobial peptides and the use thereof
#2396VISTA antagonist and methods of use
#2397Methods and Compositions Related to Cyclic Peptide Synthesis
#2398Peptide having cell membrane penetrating activity
#2399Fragments of P97 and uses thereof
#2400Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof